[1] K. Alaqad, T.A. Saleh, Gold and silver nanoparticles: synthesis methods, characterization routes and applications towards drugs, J. Environ. Anal. Toxicol., 6 (2016) 525-2161.
[2] A. Jouyban, E. Rahimpour, Optical sensors based on silver nanoparticles for determination of pharmaceuticals: An overview of advances in the last decade, Talanta, (2020) 121071.
[3] K.A. Willets, R.P. Van Duyne, Localized surface plasmon resonance spectroscopy and sensing, Annu. Rev. Phys. Chem., 58 (2007) 267-297.
[4] J. Khodaveisi, A.M.H. Shabani, S. Dadfarnia, M.R. Moghadam, M.R. Hormozi-Nezhad, Simultaneous determination of protocatechuic aldehyde and protocatechuic acid using the localized surface plasmon resonance peak of silver nanoparticles and chemometric methods, Quím. Nova, 38 (2015) 896-901.
[5] M.R. El-Zahry, A localized surface plasmon resonance sensing method for simultaneous determination of atenolol and amiloride in pharmaceutical dosage forms and urine samples, J. Anal. Methods Chem., 2018.
[6] N. Alarfaj, S. Altamimi, M. El-Tohamy, A. Almahri, Exploitation of localized surface plasmon resonance of silver/gold nanoparticles for the fluorescence quantification of angiotensin II receptor antagonists in their tablets and bio-samples, New J. Chem., 43 (2019) 492-503.
[7] Moffat, A.C., Osselton, M.D., Widdop, B., Galichet, L.Y.; Clark's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material; Vol. (II), 4th Ed. The Pharmaceutical Press, London, (2011): 1845
[8] Sweetman, S. Martindale; The complete drug reference. the Pharmaceutical Press, London,38 ed,2014; Vol. A,P.1671.
[9] K. Whalen, Lippincott illustrated reviews: pharmacology, Lippincott Williams & Wilkins, Philadelphia, 2018.
[10] The United States Pharmacopoeia 34, the National Formulary 29; the US Pharmacopoeial Convention: Rockville, MD, (2011), Vol. III,P. 3782
[11] The British Pharmacopoeia, Her Magesty's Stationary Office: London, 2019; Vol. II, p. 499.
[12] The European Pharmacopoeia 7: Council Of Europe : European Directorate for the Quality of Medicines and Healthcare, Strasbourg, 2011; Vol. (II),P.2648.
[13] T.a.N. Al-Sabha, B.A. Rasheed, Spectrophotometric determination of oxymetazoline hydrochloride based on the oxidation reactions, Jordan J. Chem., 146 (2011) 1-9.
[14] S.A. Zakaria, Spectrophotometric determination of oxymetazoline hydrochloride via oxidative coupling reaction with 4-aminoantipyrine in the presence of potassium periodate, Rafidain J. Sci., 22 (2011) 97-108.
[15] O. Abdel-Aziz, A. El-Kosasy, N. Magdy, N. El Zahar, Novel spectroscopic methods for determination of Cromolyn sodium and Oxymetazoline hydrochloride in binary mixture, Spectrochim. Acta A, 131 (2014) 59-66.
[16] M.A.M. Hegazy, M.A. Al-Ghobashy, B.M. Eltanany, F.I. Khattab, Spectral resolution and simultaneous determination of oxymetazoline hydrochloride and sodium cromoglycate by derivative and ratio-based spectrophotometric methods, Eur. J. Chem., 6 (2015) 319-324.
[17] N.S. Othman, S.A. Fathe, Indirect spectrophotometric determination of oxymetazoline hydrochloride, Rafidain J.Sci., 24 (2013) 84-95.
[18] J.O. Abdulsattar, H. Hadi, S. Richardson, A. Iles, N. Pamme, Detection of doxycycline hyclate and oxymetazoline hydrochloride in pharmaceutical preparations via spectrophotometry and microfluidic paper-based analytical device (μPADs), Anal. Chim. Acta, 1136 (2020) 196-204.
[19] F. Salama, K. Abdel-Salam, A. Abdel-Halim, R. Said, A. Madkour, Validated Spectrofluorimetric Method for The Determination of Oxymetazoline Hydrochloride via Derivatization with 4-Chloro-7-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl), Eurasian J. Anal. Chem., 13 (2018) 4.
[20] X. Yu, H. Liu, Y. Yang, S. Lu, Q. Yao, P. Yi, The investigation of the interaction between Oxymetazoline hydrochloride and mucin by spectroscopic approaches, Spectrochim. Acta A, 103 (2013) 125-129.
[21] P. Boon, W. Sudds, The gas chromatographic determination of imidazolines in pharmaceutical preparations, J. Pharm. Pharmacol., 19 (1967) Suppl: 88S.
[22] M. Massaccesi, Gas chromatographic determination of some imidazolines in pharmaceutical preparations using the FFAP in stationary phase, Pharm. Acta Helv., 62 (1987) 302.
[23] T. Hoffmann, R. Thompson, J. Seifert, Determination of the nasal decongestant, oxymetazoline hydrochloride, in pharmaceutical formulations by HPLC, Drug Dev. Ind. Pharm., 15 (1989) 743-757.
[24] B. Stanisz, W. Nowinski, Determination of oxymetazoline hydrochloride and decomposition products by high-performance liquid chromatography, Acta Pol. Pharm., 57 (2000) 399-402.
[25] S. Sudsakorn, L. Kaplan, D.A. Williams, Simultaneous determination of triamcinolone acetonide and oxymetazoline hydrochloride in nasal spray formulations by HPLC, J. Pharm. Biomed. Anal., 40 (2006) 1273-1280.
[26] K.A. Shaikh, A.T. Patil, Stability-indicating HPLC method for the determination of mometazone furoate, oxymetazoline, phenyl ethanol and benzalkonium chloride in nasal spray solution, J. Trace Anal., Food &Drugs, 1 (2013) 14-21.
[27] M.A. Hegazy, M.A. Al-Ghobashy, B.M. Eltanany, F.I. Khattab, Validated chromatographic methods for the simultaneous determination of sodium cromoglycate and oxymetazoline hydrochloride in a combined dosage form, J. Advances Chem., 11 (2015).
[28] M. Fathy, S. Abo El Abass Mohamed, H. Elmansi, F. Belal, Simultaneous Determination of Cromolyn Sodium Combined Dosage Forms Using Isocratic HPLC Method, J. Chromatogr. Sci., 55 (2016) 14-22.
[29] A.M. Garcı́a-Campaña, J.M.B. Sendra, M.P.B. Vargas, W.R. Baeyens, X. Zhang, Flow injection analysis of oxymetazoline hydrochloride with inhibited chemiluminescent detection, Anal. Chim. Acta, 516 (2004) 245-249.
[30] N.N. Wang, Y.Q. Shao, Y.H. Tang, H.P. Yin, X.Z. Wu, Flow‐injection chemiluminescence method for the determination of naphazoline hydrochloride and oxymetazoline hydrochloride, J. Lumin., 24 (2009) 178-182.
[31] Q. Chen, P. Li, H. Yang, B. Li, J. Zhu, L. Peng, Nonaqueous capillary electrophoresis conditions for the simultaneous separation of eight alpha-adrenergic blocking agents, Anal. Bioanal. Chem., 398 (2010) 937-942.
[32] A.M. Abdel-Raoof, A.H. Abdel-Monem, A.A. Almrasy, T.F. Mohamed, Z.A. Nasr, G.F. Mohamed, Optimization of Highly Sensitive Screen Printed Electrode Modified With Cerium (IV) Oxide Nanoparticles for Electrochemical Determination of Oxymetazoline Hydrochloride Using Response Surface Methodology, J. Electrochem. Soc., 167 (2020) 047502.
[33] A. Munir, B. Bozal-Palabiyik, A. Khan, A. Shah, B. Uslu, A novel electrochemical method for the detection of oxymetazoline drug based on MWCNTs and TiO2 nanoparticles, J. Electroanal. Chem., 844 (2019) 58-65.
[34] K. Mavani, M. Shah, Synthesis of silver nanoparticles by using sodium borohydride as a reducing agent, Int. J. Eng. Res. Technol., 2 (2013) 1-5.
[35] J.M. Martins, A. Farinha, Uniformity of dosage units—comparative study of methods and specifications between Eur. Pharm. 3rd and USP 23, J. Pharm. Biomed., 18 (1998) 487-495.
[36] J. Tashkhourian, M. Hormozi-Nezhad, J. Khodaveisi, Application of silver nanoparticles and principal component-artificial neural network models for simultaneous determination of levodopa and benserazide hydrochloride by a kinetic spectrophotometric method, Spectrochim. Acta A, 82 (2011) 25-30.
[37] J. Leiterer, F. Delissen, F. Emmerling, A. Thünemann, U. Panne, Structure analysis using acoustically levitated droplets, Anal. Bioanal. Chem., 391 (2008) 1221-1228.
[38] M. Tobiszewski, J. Namieśnik, Greener organic solvents in analytical chemistry, Curr. Opin. Green Sustain., 5 (2017) 1-4.
[39] J. Georges, Lanthanide-sensitized luminescence and applications to the determination of organic analytes. A review, Analyst, 118 (1993) 1481-1486.
[40] I.S. Committee, ICH harmonised tripartite guidelines. Validation of analytical procedures: methodology Q2, in: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Step, 1996.
[41] J. Miller, J.C. Miller, Statistics and chemometrics for analytical chemistry, Pearson education, 2018.